Testosterone replacement therapy

被引:9
|
作者
Velazquez, E [1 ]
Arata, GB [1 ]
机构
[1] Univ Los Andes, Sch Med, Dept Med, Endocrinol Unit, Merida, Venezuela
来源
ARCHIVES OF ANDROLOGY | 1998年 / 41卷 / 02期
关键词
male hypogonadism; testosterone replacement;
D O I
10.3109/01485019808987949
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
The benefits conferred by testosterone replacement therapy are substantial, both in the short term for the eradication of symptoms of androgen deficiency, and in the long term for the prevention of osteoporosis. As with any long-term treatment there are risks that must be considered, but overall the benefits achieved far outweigh potential risk. Ideally, androgen replacement therapy should provide physiological serum testosterone levels, as well as DHT and estradiol levels, and correct the clinical symptoms of androgen deficiency in hypogonadal men. This goal is difficult to achieve because the dose dependency of androgen-dependent physiological processes is not known. Androgen preparations that are currently available do not fulfill all criteria for an ideal androgen replacement therapy. Parenteral testosterone esters are effective, safe, practical, and inexpensive. The transdermal testosterone systems provide an alternative to testosterone esters in selected patients but these preparations are expensive. Ongoing studies are showing the benefits of testosterone replacement therapy in aging men, but there is concern about side effects on cardiovascular system and prostate. Thus, clinical decision regarding testosterone therapy in older men should be better defined.
引用
收藏
页码:79 / 90
页数:12
相关论文
共 50 条
  • [31] Testosterone replacement therapy and erectile dysfunction
    Onyeji, Ifeanyi C.
    Clavijo, Raul, I
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2022, 34 (07) : 698 - 703
  • [32] PROSTATIC COMPLICATIONS OF TESTOSTERONE REPLACEMENT THERAPY
    JACKSON, JA
    WAXMAN, J
    SPIEKERMAN, AM
    ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (10) : 2365 - 2366
  • [33] Testosterone Replacement Therapy and the Risk of Hypoglycemia
    Veronica Yamaguchi, Analia
    Rene Costanzo, Pablo
    Andrea Peuchot, Veronica
    Knoblovits, Pablo
    CASE REPORTS IN ENDOCRINOLOGY, 2019, 2019
  • [34] Blood donation and testosterone replacement therapy
    Chin-Yee, Benjamin
    Lazo-Langner, Alejandro
    Butler-Foster, Terrie
    Hsia, Cyrus
    Chin-Yee, Ian
    TRANSFUSION, 2017, 57 (03) : 578 - 581
  • [35] Testosterone replacement therapy and the knowledge gap
    Yooni A. Yi
    James M. Dupree
    Nature Reviews Urology, 2017, 14 : 332 - 333
  • [36] Transdermal testosterone replacement therapy in men
    Ullah, M. Iftekhar
    Riche, Daniel M.
    Koch, Christian A.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 101 - 112
  • [37] Testosterone Replacement Therapy and Prostate Health
    A. Scott Polackwich
    Kevin A. Ostrowski
    Jason C. Hedges
    Current Urology Reports, 2012, 13 : 441 - 446
  • [38] Risks of testosterone replacement therapy in men
    Osterberg, E. Charles
    Bernie, Aaron M.
    Ramasamy, Ranjith
    INDIAN JOURNAL OF UROLOGY, 2014, 30 (01) : 2 - 7
  • [39] Pharmacology of testosterone replacement therapy preparations
    Shoskes, Jennifer J.
    Wilson, Meghan K.
    Spinner, Michael L.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2016, 5 (06) : 834 - 843
  • [40] Testosterone replacement therapy and voiding dysfunction
    Baas, Wesley
    Koehler, Tobias S.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2016, 5 (06) : 890 - 897